1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Hodgkins Lymphoma: new trials by email Literature Review of Hodgkins Lymphoma trials Research Report on Hodgkins Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HD18 for Advanced Stages in Hodgkins Lymphoma Rituximab, BEACOPP escalated - Hodgkins Lymphoma | Phase 3 | Completed | University of Cologne | 1500 | 2008-05-01 | 2020-11-13 |
Hodgkin Disease (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Rituximab (1)
Germany (1)
PMID 23225085, PMID 28236583, PMID 29061295, PMID 30010775, PMID 30166329, PMID 34048679, PMID 40135712, PMID 41074963, PMID 42379221